RxDoctor Payments Data

Madeline Ondrak, PA

Physician Assistant · Hastings, NENPI 1518644210

Payments from drug & device makers

$1,731in general payments, 2019–2025

Across 82 payments — averaging $21.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$260
  • Lilly USA, LLC$247
  • Aimmune Therapeutics, Inc.$216
  • Novo Nordisk$171
  • AbbVie$142
  • Pfizer$131
  • plus $565 from 13 others

What the payments were for

  • Food & beverage$1,66396%
  • Education$684%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,731 in reported general payments places this provider in the 80th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$132,594
Medicare patients
520
Services billed
4,709

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate120$883
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav93$653
Omeprazole28$510
CefuroximeCefuroxime Axetil23$383
Losartan Potassium34$352
Potassium Chloride30$335
Levothyroxine Sodium43$300
Ramipril26$284
Fluticasone Propionate11$225
Pantoprazole Sodium20$129
Prednisone54$126
Furosemide25$125
Cephalexin30$114
Amlodipine Besylate18$106
Atorvastatin Calcium14$93

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerPaxlovid$131$011 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Hastings

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →